A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma

Intratumor heterogeneity (ITH) is an inherent process in cancer development which follows for most of the cases a branched pattern of evolution, with different cell clones evolving independently in space and time across different areas of the same tumor. The determination of ITH (in both spatial and temporal domains) is nowadays critical to enhance patient treatment and prognosis. Clear cell renal cell carcinoma (CCRCC) provides a good example of ITH. Sometimes the tumor is too big to be totally analyzed for ITH detection and pathologists decide which parts must be sampled for the analysis. For such a purpose, pathologists follow internationally accepted protocols. In light of the latest findings, however, current sampling protocols seem to be insufficient for detecting ITH with significant reliability. The arrival of new targeted therapies, some of them providing promising alternatives to improve patient survival, pushes the pathologist to obtain a truly representative sampling of tumor diversity in routine practice. How large this sampling must be and how this must be performed are unanswered questions so far. Here we present a very simple method for tumor sampling that enhances ITH detection without increasing costs. This method follows a divide-and-conquer (DAC) strategy, that is, rather than sampling a small number of large-size tumor-pieces as the routine protocol (RP) advises, we suggest sampling many small-size pieces along the tumor. We performed a computational modeling approach to show that the usefulness of the DAC strategy is twofold: first, we show that DAC outperforms RP with similar laboratory costs, and second, DAC is capable of performing similar to total tumor sampling (TTS) but, very remarkably, at a much lower cost. We thus provide new light to push forward a shift in the paradigm about how pathologists should sample tumors for achieving efficient ITH detection.

[1]  Antonio Lopez-Beltran,et al.  2004 WHO classification of the renal tumors of the adults. , 2006, European urology.

[2]  Sohrab P. Shah,et al.  TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data , 2014, Genome research.

[3]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[4]  Hilbert J. Kappen,et al.  Effects of Fast Presynaptic Noise in Attractor Neural Networks , 2005, Neural Computation.

[5]  W Marston Linehan,et al.  Intratumoral heterogeneity in kidney cancer , 2014, Nature Genetics.

[6]  The Cancer Genome Atlas Research Network COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.

[7]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[8]  P. A. Futreal,et al.  Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.

[9]  T. Tsuzuki,et al.  Tyrosine kinase inhibitor‐induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism , 2014, Histopathology.

[10]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[11]  Ella L. Kim,et al.  Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment , 2014, Front. Oncol..

[12]  C. Swanton,et al.  How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma? , 2015, Current opinion in urology.

[13]  Benjamin J. Raphael,et al.  Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data , 2014, Bioinform..

[14]  J. López,et al.  Cell heterogeneity in clear cell renal cell carcinoma , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  Noemi Andor,et al.  EXPANDS: expanding ploidy and allele frequency on nested subpopulations , 2013, Bioinform..

[16]  B. L. Hayllar,et al.  Neoplasms of the kidney. , 1949, Pennsylvania medical journal.

[17]  Charles Swanton,et al.  Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine , 2014, Genome Biology.

[18]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[19]  Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology. , 2009, Human pathology.

[20]  E. Jonsson,et al.  Incidental detection of renal cell carcinoma is an independent prognostic marker: results of a long-term, whole population study. , 2012, The Journal of urology.

[21]  Joaquín J. Torres,et al.  Chaotic hopping between attractors in neural networks , 2006, Neural Networks.

[22]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[23]  Joaquín J. Torres,et al.  Switching between memories in neural automata with synaptic noise , 2004, Neurocomputing.

[24]  J. López Renal tumors with clear cells. A review. , 2013, Pathology, research and practice.

[25]  Xin-She Yang,et al.  Introduction to Algorithms , 2021, Nature-Inspired Optimization Algorithms.

[26]  L. Zaldumbide,et al.  Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous , 2014, Virchows Archiv.

[27]  Ann-Marie Baker,et al.  Tumour Cell Heterogeneity , 2016, F1000Research.

[28]  J. Cheville,et al.  Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression. , 2016, The Journal of urology.

[29]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[30]  B. Delahunt,et al.  Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology , 2011, Journal of Clinical Pathology.

[31]  B. Delahunt,et al.  Handling and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations , 2013, The American journal of surgical pathology.

[32]  J. López Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist , 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[33]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[34]  Hanlee P. Ji,et al.  Pan-cancer analysis of the extent and consequences of intratumor heterogeneity , 2015, Nature Medicine.

[35]  G. Cancel-Tassin,et al.  Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine , 2012, BJU international.